CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jinling Pharmaceutical Company Limited Company Snapshot
Jinling Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jinling Pharmaceutical Company Limited with three other companies in this sector in CHINA : Jiang Zhong Pharmaceutical Co Ltd (2019 sales of 2.45 billion Chinese Renmimbi [US$358.87 million] of which 99% was Medical Industry), Guangdong Zhongsheng Pharmaceutical Co Ltd (2.53 billion Chinese Renmimbi [US$370.97 million] of which 90% was Medicine Manufacture), and Autobio Diagnostics Co Ltd (2.68 billion Chinese Renmimbi [US$392.64 million] of which 97% was In vitro diagnosis).

Sales Analysis. Jinling Pharmaceutical Company Limited reported sales of 2.53 billion Chinese Renmimbi (US$371.47 million) for the year ending December of 2019. This represents a decrease of 12.6% versus 2018, when the company's sales were 2.90 billion Chinese Renmimbi. The sales level in 2019 was fairly close to the level five years ago: in 2014, Jinling Pharmaceutical Company Limited had sales of 2.77 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 66.0% decline in Other, from 76.39 million Chinese Renmimbi to 25.98 million Chinese Renmimbi. There were also decreases in sales in Medicine Manufacturing (down 20.7% to 1.37 billion Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Medical Service (up 4.0% to 1.14 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jinling Pharmaceutical Company Limited
  Stock Performance Chart for Jinling Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 6.63
(Figures in Chinese Renmimbi)
1 Week -2.5%   13 Weeks -6.5%  
4 Weeks -1.8%   52 Weeks -10.2%  
 
Jinling Pharmaceutical Company Limited Key Data:
  Ticker: 000919 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 2,534,920,540
(Year Ending Jan 2020).
Employees: 4,767
  Currency: Chinese Renmimbi Market Cap: 3,341,520,000
  Fiscal Yr Ends: December Shares Outstanding: 504,000,000
  Share Type: A Gu Closely Held Shares: 310,805,073
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.